tert-Butyl (2R,5S)-5-(hydroxymethyl)-2-methylpiperidine-1-carboxylate, 98%, 10g

2-((Benzyloxy)imino)acetic acid, 97%, 25g

Orange terpenes, pure, 1L, glass packaging

(5R)-ethyl 5-((1R,3aS,7aR)-4-((E)-2-((3S,5R)-3,5-bis(tert-butyldimethylsilyloxy)-2-methylenecyclohexylidene)ethyl)-7a-methyloctahydro-1H-inden-1-yl)hexanoate, 98%, 500mg

4-(1H-Imidazol-2-yl)benzoic acid hydrochloride, 95+%, 250mg

5-Bromo-2-(4-chlorophenoxy)pyrimidine, 97.0%, 1g

1-(2-Bromoethoxy)-4-nitrobenzene, 95.0%, 25g

Ethyl N-Boc-4-oxo-pyrrolidine-3-carboxylate, 95.0%, 5g

2-Amino-6-fluorobenzonitrile>98.0%(GC)25g

(R)-2,2'-Dihydroxy-[1,1'-binaphthalene]-3,3'-dicarboxaldehyde, 97%, 50mg

Glass vials with rolled rim Short, 30 ml, Height, 72 mm, 108 Piece(s)

Myrcene (stabilized with BHT)>75.0%(GC)500mL

N-([1,1'-Biphenyl]-4-yl)-N-(4-(9-phenyl-9H-carbazol-3-yl)phenyl)-[1,1'-biphenyl]-4-amine, 5g